Clinical Trial

Cardiovascular Outcomes of Low Testosterone

Study Description

Cardiovascular Outcomes of Low Testosterone

This study plans to learn more about heart and vascular aging in men. In some men as they get older, testosterone levels fall below the normal range for young men. Also, as men get older cardiovascular health worsens. This can lead to high blood pressure and heart disease. In this study we want to find out what causes cardiovascular health to worsen in older men. Also we want to find out what happens when testosterone levels are lowered for a short time. Specifically, we want to see if the reduction in cardiovascular health in older men with low testosterone levels is because of damage to mitochondria. Mitochondria are the main power supply of the cells in our body. The results from this study will help to understand why cardiovascular health declines in older men with low testosterone levels compared to younger men and older men who have higher testosterone levels. Knowing this information will help to develop therapies to prevent heart disease in men.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Acyline

Acyline 300ug/kg injection will be administered on Day 0 and on day 14

Drug - Placebo Gel

Placebo gel packet applied daily for 28 days.

Drug - Placebo Tablet

Placebo oral tablet taken daily for 28 days.

Drug - Testosterone Gel

Testosterone Gel applied daily for 28 days

Drug - Arimidex

Arimidex Oral Tablet 1mg taken orally daily for 28 days

Additional Information

Official Study Title

Cardiovascular Consequences of Hypogonadism in Men

Clinical Trial ID

NCT02758431

ParticipAid ID

9aAX9e